These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17961615)

  • 21. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization.
    Kohl KS; Magnus M; Ball R; Halsey N; Shadomy S; Farley TA
    Vaccine; 2008 Nov; 26(50):6349-60. PubMed ID: 18805456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The vaccine conundrum. Should parents be concerned about the number of childhood inoculations?
    Hobson K
    US News World Rep; 2003 Mar; 134(8):44-5. PubMed ID: 12645308
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevention of contagious diseases].
    Wehrlin N
    Rev Infirm; 1981 Apr; 31(7):35-42. PubMed ID: 6910084
    [No Abstract]   [Full Text] [Related]  

  • 25. Obstetrical and neonatal case definitions for immunization safety data.
    Chen RT; Moro PL; Bauwens J; Bonhoeffer J
    Vaccine; 2016 Dec; 34(49):5991-5992. PubMed ID: 27554535
    [No Abstract]   [Full Text] [Related]  

  • 26. National Immunization Information Hotline: Calls concerning adverse events, 1998-2000.
    Gust DA; Gangarosa P; Hibbs B; Pollard R; Wallach G; Chen RT
    J Health Commun; 2004; 9(5):387-94. PubMed ID: 15513788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vaccination].
    Wehrlin N
    Rev Infirm; 1985 Jul; 35(13):45-51. PubMed ID: 3849865
    [No Abstract]   [Full Text] [Related]  

  • 28. Rural parents' perspectives about information on child immunization.
    Miller NK; Verhoef M; Cardwell K
    Rural Remote Health; 2008; 8(2):863. PubMed ID: 18384249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse events temporally associated with immunizing agents--1989 report.
    Duclos P; Koch J; Hardy M; Carter A; McCarthy R
    Can Dis Wkly Rep; 1991 Jul; 17(29):147-51, 155-7. PubMed ID: 1913934
    [No Abstract]   [Full Text] [Related]  

  • 30. Collaborative improves monitoring of vaccine safety.
    Gearon CJ
    AHIP Cover; 2007; 48(5):16-8, 20, 22-4. PubMed ID: 17941571
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adverse events following immunization and causality assessment of an adverse event following immunization].
    Yao KH; Yang YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan; 16(1):1-4. PubMed ID: 24461168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems.
    Bonhoeffer J; Bentsi-Enchill A; Chen RT; Fisher MC; Gold MS; Hartman K; Heininger U; Hoet B; Jefferson T; Khuri-Bulos N; Kohl K; Marcy SM; Nalin D; Pless R; Sanabria-Rojas H; Sleeman K; Wise R;
    Vaccine; 2009 Apr; 27(16):2289-97. PubMed ID: 19061929
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety of Typhim Vi vaccine in a postmarketing observational study.
    Marcus LC; Froeschle JE; Hill DR; Wolfe MS; Maus D; Connor B; Acosta AM; Rensimer ER; Roberts A; Dardick K
    J Travel Med; 2007; 14(6):386-91. PubMed ID: 17995534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of vaccine surveillance data in the evaluation of safety of vaccines.
    Postila V; Kilpi T
    Vaccine; 2004 May; 22(15-16):2076-9. PubMed ID: 15121327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parents with doubts about vaccines: which vaccines and reasons why.
    Gust DA; Darling N; Kennedy A; Schwartz B
    Pediatrics; 2008 Oct; 122(4):718-25. PubMed ID: 18829793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supplementary report: Surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2011.
    Mahajan D; Cook J; McIntyre P; Macartney K; Menzies R
    Commun Dis Intell Q Rep; 2012 Mar; 36(1):114-9. PubMed ID: 23153088
    [No Abstract]   [Full Text] [Related]  

  • 37. Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies.
    Bonhoeffer J; Bentsi-Enchill A; Chen RT; Fisher MC; Gold MS; Hartman K; Heininger U; Hoet B; Jefferson T; Khuri-Bulos N; Kohl KS; Marcy SM; Nalin D; Pless R; Sanabria-Rojas H; Sleeman K; Wise R;
    Vaccine; 2009 Apr; 27(16):2282-8. PubMed ID: 19056451
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccine adverse event monitoring systems across the European Union countries: time for unifying efforts.
    Zanoni G; Berra P; Lucchi I; Ferro A; O'Flanagan D; Levy-Bruhl D; Salmaso S; Tridente G
    Vaccine; 2009 May; 27(25-26):3376-84. PubMed ID: 19200851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supplementary report: surveillance of adverse events following immunisation among children aged < 7 years in Australia, 1 January to 30 June 2008.
    Lawrence GL; Mahajan D; Roomiani I
    Commun Dis Intell Q Rep; 2009 Mar; 33(1):27-31. PubMed ID: 19618765
    [No Abstract]   [Full Text] [Related]  

  • 40. Calling the shots without calling them 'shots'.
    Leccese C
    Adv Nurse Pract; 1999 Feb; 7(2):51-3. PubMed ID: 10358479
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.